HETERO LABS LTD III FDA Approval ANDA 210914

ANDA 210914

HETERO LABS LTD III

FDA Drug Application

Application #210914

Application Sponsors

ANDA 210914HETERO LABS LTD III

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL2.5MG/5ML0LEVOCETIRIZINE HYDROCHLORIDELEVOCETIRIZINE DIHYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2019-04-01STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAA

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210914
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVOCETIRIZINE HYDROCHLORIDE","activeIngredients":"LEVOCETIRIZINE DIHYDROCHLORIDE","strength":"2.5MG\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/01\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"09\/23\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-09-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.